Is it safe to use erythropoiesis-stimulating agents to treat anemia in chronic kidney disease patients with active malignancies?

Authors


Address correspondence to: Michael J. Choi, Division of Nephrology, Department of Internal Medicine, Johns Hopkins University, 1830 East Monument St, Baltimore, MD 21205, USA, Tel.: 410-955-5268, Fax: 410-955-0485, or e-mail: mchoi3@jhmi.edu.

No abstract is available for this article.

Ancillary